SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

Janney Capital Maintains Buy on Marker Therapeutics, Lowers Price Target to $10

Janney Capital maintains Marker Therapeutics (NASDAQ:MRKR) with a Buy and lowers the price target from $15 to $10.

Benzinga · -

Janney Capital maintains Marker Therapeutics (NASDAQ:MRKR) with a Buy and lowers the price target from $15 to $10.